📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The ex vivo perfused human lung is resistant to injury by high-dose S. pneumoniae bacteremia. (2020)

First Author: Ross JT

Attributed to: Can combined cellular and 11beta-hydroxysteroid dehydrogenase-1 gene therapy attenuate inflammation in acute respiratory distress syndrome? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1152/ajplung.00053.2020

PubMed Identifier: 32519893

Publication URI: http://europepmc.org/abstract/MED/32519893

Type: Journal Article/Review

Volume: 319

Parent Publication: American journal of physiology. Lung cellular and molecular physiology

Issue: 2

ISSN: 1040-0605